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NF-kB transcription factors function as crucial regulators of inflammatory and immune responses as well as of cell survival 1 . They have also been implicated in cellular transformation and tumorigenesis [2] [3] [4] [5] [6] . However, despite extensive biochemical characterization of NF-kB signalling during the past twenty years, the requirement for NF-kB in tumour development in vivo, particularly in solid tumours, is not completely understood. Here we show that the NF-kB pathway is required for the development of tumours in a mouse model of lung adenocarcinoma. Concomitant loss of p53 (also known as Trp53) and expression of oncogenic Kras(G12D) resulted in NF-kB activation in primary mouse embryonic fibroblasts. Conversely, in lung tumour cell lines expressing Kras(G12D) and lacking p53, p53 restoration led to NF-kB inhibition. Furthermore, the inhibition of NF-kB signalling induced apoptosis in p53-null lung cancer cell lines. Inhibition of the pathway in lung tumours in vivo, from the time of tumour initiation or after tumour progression, resulted in significantly reduced tumour development. Together, these results indicate a critical function for NF-kB signalling in lung tumour development and, further, that this requirement depends on p53 status. These findings also provide support for the development of NF-kB inhibitory drugs as targeted therapies for the treatment of patients with defined mutations in Kras and p53.
More than one million people worldwide die from lung cancer each year, making it the leading cause of cancer mortality in both women and men. Non-small-cell lung cancer (NSCLC) accounts for 80% of all lung cancer cases, with adenocarcinoma being the major subtype. NSCLC development is associated with frequent mutations in a few well-defined oncogenes and tumour suppressor genes. Oncogenic Kras mutations occur in approximately 20-30% of patients with lung adenocarcinoma, whereas inactivating mutations in the tumour suppressor protein p53 are found in at least 50% of NSCLC cases 7 . The overexpression of oncogenic forms of Ras has been reported to result in NF-kB activation 3, 8 , whereas wild-type p53 has been shown to antagonize NF-kB activity [9] [10] [11] [12] [13] [14] . Therefore, we proposed that induction of endogenous Kras(G12D) or p53 deletion might affect the NFkB signalling pathway. We used primary mouse embryonic fibroblasts (MEFs) carrying either the Cre-activatable Kras(G12D) allele (Kras LSL-G12D/WT , in which LSL denotes Lox-stop-Lox ), a conditional loss-of-function p53 allele (p53 Flox/Flox ), or the two in combination (Kras LSL-G12D/WT ; p53 Flox/Flox ) [15] [16] [17] . Cells were infected with adenoviruses expressing either Cre (to activate oncogenic Kras and/or inactivate p53) or FlpO recombinase (as a control). As shown in Fig. 1a , activation of Kras(G12D) with concomitant loss of p53 led to an increased nuclear accumulation of the NF-kB transcription factor subunit p65 (also known as Rela), a prerequisite for NF-kB activity. In contrast, p65 remained exclusively cytoplasmic after Kras(G12D) expression in wild-type p53-expressing cells or after loss of p53 in the absence of Kras(G12D) expression, suggesting that the combination of mutations is required for enhanced NF-kB activation, at least in these cells. Of note, another NF-kB subunit, c-Rel, showed a slight increase in nuclear localization after p53 loss, both alone and after Kras(G12D) expression (Fig. 1a) , perhaps reflecting crosstalk between p53 and c-Rel.
We next addressed whether restoration of p53 expression in p53-mutant cells might influence p65 nuclear localization. We used Kras(G12D)-expressing lung adenocarcinoma cell lines with a Creactivatable wild-type p53 allele, which were derived from lung ; Cre-ER T2 -lung-tumour-derived cells were untreated (ctrl), cultured in 0.1% FBS or stimulated with 200 nM 4-hydroxytamoxifen (OHT). After 4 days, cells were lysed and analysed as in a (b), or RNA was purified, reverse transcribed, and complementary DNA was amplified using probes for Glut3, Tnf or Gapdh (internal control) (c). Results are means and s.d. (n 5 3 independent cell lines), presented as fold changes (treatment divided by control; see Methods) 30 .
tumours of mice generated by the crossing of Kras LA2/WT (ref. 18 ) and p53 LSL/LSL ; Cre-ER T2 (ref. 19 ) mice (D.M.F. and T.J., unpublished data). In the absence of p53 restoration, nuclear p65 was evident in these cells, consistent with the data from MEFs (see Fig. 1a ). After 4-hydroxytamoxifen-induced p53 restoration, p65 nuclear localization was diminished (Fig. 1b) . In contrast, the nuclear levels of c-Rel remained unchanged. Reduced levels of nuclear p65 were not simply a consequence of cell cycle arrest, because p65 remained detectable in the nucleus of cells arrested by culturing in 0.1% serum. Notably, restoration of p53 and decreased nuclear p65 expression were associated with reduced expression of the NF-kB-target gene Tnf (Fig. 1c) . The expression of Glut3, which contributes to and is upregulated by NF-kB activity in p53-deficient MEFs 10 , was also reduced after restoration of p53 (Fig. 1c) . Using enzyme-linked immunosorbent assay (ELISA), we directly monitored NF-kB activity in lung adenocarcinoma cell lines derived from tumours generated in the conditional compound knock-in (Kras
LSL-G12D/WT
; p53 Flox/Flox ) mouse. These mice (hereafter referred to as KP mice) develop advanced lung cancers that closely recapitulate the development of human lung adenocarcinoma 15 . In KP tumour cell lines, NF-kB p65 DNA-binding activity was consistently higher than in cell lines derived from the Kras LA2/WT allele (LKR), which also express Kras(G12D) but retain wild-type p53 expression (Fig. 2a) . We also examined NF-kB activity in human NSCLC cell lines that contain gain-of-function mutations in Kras but differ in their p53 status. Consistent with the mouse data, NF-kB p65 DNA-binding activity was increased in p53 mutant compared to wild-type p53 cell lines, with one exception (Fig. 2b) . Notably, nuclear p65 was higher in the p53 mutant cells ( Supplementary Fig. 1 ). Hence, canonical NF-kB signalling is increased in lung tumour-derived cells with altered p53.
To determine whether NF-kB provides pro-survival signals in KP cell lines, we examined the consequences of pathway inhibition. Cell viability was monitored after infection of cells with lentiviruses expressing a non-phosphorylatable, dominant-negative form of IkBa (encoded by Nfkbia; super repressor, IkB-SR). As shown in Fig. 3a , the expression of IkB-SR led to reduced KP cell viability. In contrast, the two LKR cell lines expressing mutant Kras and wild-type p53 (LKR10 and LKR13) were insensitive to IkB-SR expression. These results are consistent with the data showing increased NF-kB activity in KP cells (see Fig. 2a ). NF-kB signalling was also inhibited by short hairpin RNA (shRNA)-mediated knockdown of NEMO (also known as Ikbkg), an essential factor in the canonical NF-kB pathway 20, 21 . Infection of LKR, KP and 3TZ fibroblast cell lines with pSicoRev retroviral vectors 22 expressing one of two hairpins targeting NEMO resulted in efficient knockdown in all cases, whereas apoptosis (as measured by cleaved caspase-3 detection) was only triggered in the KP cell line (Fig. 3b) . To establish whether one of the two NF-kB subunits, p65 or c-Rel, transmitted these anti-apoptotic effects, we used shRNA-mediated knockdown to inhibit them in the same cells. Knockdown of p65, but not of c-Rel, led to reduced cell viability and cleavage of caspase-3 ( Fig. 3c, d ). These results demonstrate that in the context of oncogenic Kras expression and p53 mutation, the canonical NEMO-, IkB-and p65-dependent NF-kB signalling pathway is required for survival of lung cell lines.
To understand the relevance of these findings in vivo, we examined the NF-kB signalling pathway during lung adenocarcinoma development in KP mice. Tumours from KP mice had enhanced NF-kB p65 nuclear localization by immunohistochemistry when compared to tumours from Kras(G12D) mice (Kras LSL-G12D/WT ; Supplementary  Fig. 2 ). To test the functional requirement for NF-kB in tumour initiation and development, we infected KP mice with a bifunctional lentivirus capable of expressing both IkB-SR and Cre constitutively from independent promoters or a control lentivirus carrying only Cre (Supplementary Fig. 3a) . Each mouse was either infected with low-(5 3 10 3 ) or high-(5 3 10 4 ) titre lentiviral particles. Seventeen weeks after infection with low-titre control viruses, an average of 30 tumours was detected per mouse (Fig. 4a, left) , whereas mice infected with lentiviruses expressing Cre and IkB-SR had either a single tumour or none at all. Using the high-titre lentiviruses, a similarly notable difference between Cre-and IkB-SR-Cre-infected mice was observed (90-131 tumours compared to 6-22; Fig. 4a, right) . Thus, the inhibition of NF-kB at the time of tumour initiation in the KP mouse model had a profound effect on subsequent tumour development. To determine whether NF-kB was required to maintain the growth and/or viability of established tumours, we cloned IkB-SR into a lentiviral construct downstream of a tetracycline-response element (TRE), to generate a doxycycline (Dox)-inducible version of IkB-SR (see Supplementary  Fig. 3a, b) . KP mice were crossed to clara cell secretory protein (CCSP, also known as Scgb1a1)-rtTA transgenic mice, which express the reverse tetracycline transactivator (rtTA) specifically in lung epithelial cells 23 . KP; CCSP-rtTA 1 mice and KP; CCSP-rtTA 2 littermate controls were infected with TRE.IkB-SR; Pgk.Cre lentiviruses to initiate tumorigenesis. In an initial experiment, infected mice were put on a Dox diet continuously from the day of infection. After 15 weeks, lung tumour development was analysed using in vivo micro-computed tomography (m-CT) imaging. As we observed with constitutive IkB-SR expression, Dox-mediated IkB-SR induction from the time of tumour initiation led to a significant impairment of tumour development (Fig. 4b) . To address the role of NF-kB in tumour maintenance, cohorts of infected mice were imaged by m-CT at 15 weeks post-infection to establish pretreatment lung tumour volumes. One week later, the mice were placed on a Dox diet to induce the expression of IkB-SR specifically in the tumour cells, and imaged weekly for a total of 5 weeks. As shown in Fig. 4c , IkB-SR expression resulted in a significantly diminished tumour growth rate over time compared to controls. Thus, established tumours with an activating mutation in Kras and loss of p53 function are sensitive to NF-kB inhibition.
To begin to explore the effects of NF-kB inhibition in this system, we examined the expression levels of certain NF-kB target genes by real-time PCR after 1 week of Dox treatment, starting at 14 weeks post-infection. Of note, IkBa levels (which correspond to both endogenous IkBa and the exogenous IkB-SR) were about fivefold higher in IkB-SR-expressing tumours, demonstrating the efficiency of the Doxinducible system (Fig. 4d and Supplementary Table 1 ). Contrary to our expectations, the expression of three NF-kB targets that inhibit apoptosis, Bcl2, Bclx (also known as Bcl2l1) and Xiap, did not significantly change after Dox treatment. In contrast, Tnf and Il6 messenger RNA levels were increased in tumours expressing IkB-SR. The induction of these inflammatory genes is probably due to infiltrating inflammatory cells recruited to tumours in which NF-kB has been inhibited ( Supplementary Fig. 4) . Such an inflammatory response has been observed after NF-kB repression in liver and intestinal epithelial cells 4, 24 . Future experiments will examine the importance of inflammation in the anti-tumour response.
Lung cancer is the leading cause of cancer death in the world. To develop more effective treatments, it is essential to characterize the pathways that control tumour cell proliferation and survival, which will differ depending on the specific genetic context of individual tumours. Our data establish a critical role for the NF-kB pathway in lung cancer cells containing mutations in the commonly mutated genes Kras and p53. These results, which corroborate earlier studies demonstrating the importance of NF-kB signalling in a chemicalinduced lung tumour model 25 , provide a basis to consider the pharmacological inhibition of the NF-kB pathway in the treatment of lung cancer. Because canonical NF-kB signalling has anti-inflammatory and immunosuppressive functions in macrophages 26, 27 -phenotypes that are regularly observed in tumour-associated macrophages-NFkB inhibition might have dual functions. Indeed, NF-kB inhibition may directly affect tumour epithelial cell survival and the tumour microenvironment, by recruiting and/or converting neutrophils or macrophages towards pro-inflammatory and tumoricidal phenotypes.
The therapeutic inhibition of NF-kB has been viewed with caution upon the discovery of diverse functions of this pathway in different physiological instances 28 . Our study indicates a re-evaluation of the importance of targeting NF-kB in cancer. With an a priori knowledge of the genetic mutations of the tumours, treatment with NF-kB inhibitors may become an important option for targeted therapy of lung cancer. 23 , purchased from the Jackson Laboratory, were crossed to KP mice. A 625 doxycycline diet was from Harlan Laboratories. Mouse research was approved by the Committee for Animal Care, and conducted in compliance with the Animal Welfare Act Regulations and other Federal statutes relating to animals and experiments involving animals, and adheres to the principles set forth in the Guide for the Care and Use of Laboratory Animals, National Research Council, 1996 (institutional animal welfare assurance no. A-3125-01). Virus production and infection. 293T cells were transfected using Fugene (Roche) with pMD2G (VSV-G protein), D8.2 (lentivirus packaging vector, provided by I. Verma) and expression plasmid. Viral supernatants were collected 48 and 72 h after transfection, filtered and used directly for infection of cell lines. For mouse experiments, virus preparation and mouse infection protocols were previously described 29 . Two-to-three-month-old mice were intratracheally infected with 5 3 10 3 , 10 4 or 5 3 10 4 lentiviral particles, or with 10 7 adenoviral particles expressing Cre (AdCre), as indicated. 
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Measurement of lung tumour volumes. Mice were anaesthetized using isoflurane, and were under anaesthesia during the entire scanning procedure. Lungs were imaged at the Koch Institute Microscopy and Imaging Core Facility by m-CT. Image acquisition was performed using eXplore Scan Control software, using a 45-mm voxel size program, and three-dimensional reconstruction was performed using eXplore Reconstruction Utility software (both from GE Healthcare). Highresolution files of the lung scans were generated and individual tumour volumes were measured and calculated using MicroView software (GE Healthcare). For  Fig. 4b , the lung surface opacity was set to 25%. Histology and immunohistochemistry. Mouse lungs were inflated and then fixed in 3.6% formaldehyde in PBS for 24 h, transferred to 70% ethanol, and embedded in paraffin. Four-micrometre tissue sections were deparaffinized and stained with haematoxylin and eosin to count tumour numbers (Fig. 4a) , or were used for immunohistochemistry. In this case, sections were deparaffinized, boiled in 10 mM Na-citrate, washed in H 2 O, treated with 1% H 2 O 2 for 10 min, washed in H 2 O and in PBS. Blocking was done for 1 h in PBS with 5% goat serum, followed by incubation with anti-p65 antibodies (C-20, 1/200) for 1 h, then by washing and staining with biotin-conjugated secondary antibodies (1 h). After washing, avidin-biotin horseradish peroxidase (HRP) complexes were added during 30 min (ABC kit, Vectastain), and the complexes were revealed with a DAB peroxidase substrate kit (Vector Laboratories). The tissues were counterstained with methyl green and mounted. Expression vectors. IkB super-repressor (IkB-SR) was cloned from a mouse expressed sequenced tag with a 59 oligonucleotide that added an EcoRI site followed by a Kozak sequence before the start codon, and mutating codons for Ser 32 and Ser 36 into alanine-encoding ones. The 39 oligonucleotide introduced a silent mutation removing an EcoRI site in the gene sequence, deleted the IkB stop codon, added a Flag-tag sequence followed by a stop and a NotI site. IkB-SR was amplified using Pfx polymerase (Invitrogen), and was cloned into EcoRINotI sites located next to a Ubc promoter in a dual-promoter lentiviral vector that also expresses Cre from the Pgk promoter. To generate a doxycycline-responsive Flag-IkB-SR version, IkB-SR was PCR amplified with oligonucleotides adding EcoRI sites on both ends, and cloned into an EcoRI-digested TRE; Pgk.Cre lentiviral vector (pCW22), downstream of the TRE promoter. shRNAs against NEMO, c-Rel and p65 were designed by the pSICOLIGOMAKER 1.5 program (http://web. mit.edu/jacks-lab/protocols/pSico.html; created by A. Ventura, Memorial SloanKettering Cancer Center). Oligonucleotides were annealed and ligated into pSicoRev retroviral vectors, as described Statistics. P values were determined by Student's t-tests. Nuclear-cytoplasmic fractionations. Cells in 10-cm dishes were washed with cold PBS and collected by scraping after the addition of lysis buffer A (20 mM HEPES, pH 7.6, 20% glycerol, 10 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol (DTT), 0.1% NP-40 and a proteinase inhibitor cocktail (Roche)). Lysis was completed on ice for 10 min. Supernatants containing the cytoplasmic fractions were collected after centrifugation (400g, 4 uC, 5 min). The pellets were washed three times in lysis buffer A and then lysed in buffer B (20 mM HEPES, pH 7.6, 20% glycerol, 500 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM DTT, 0.1% NP40 and a proteinase inhibitor cocktail (Roche)) for 30 min on ice. After centrifugation (15,000g, 4 uC, 15 min), the recovered supernatants containing the nuclear lysates were collected and frozen (270 uC) until use. For Fig. 1a , the data are representative of two independent experiments each performed on two different MEF preparations. For Fig. 1b , the data are representative of results obtained from three independent cell lines. Cell viability assay. Cells were split into 96-well plates (3,000 cells per well). After 24 h, cells were infected with the indicated retro-or lentiviruses, and 72 h later cells were fixed in methanol (10 min), dried (15 min), stained (10 min) in methylene blue dye (0.05% methylene blue in 13 borate buffer (103 borate buffer, pH 8.4, consists of 100 mM H 3 BO 3 , 25 mM Na 2 BO 7 and 120 mM NaCl)), washed three times under gentle tap water, and dried (2 h, 37 uC). After solubilization with 0.1 M HCl, cell viability was measured on a spectrophotometer (A 650 nm ). Non-infected cell values were set to 1 (100% viability). RNA purification, reverse transcription and real-time PCR amplification. RNA was purified using Trizol (Invitrogen), according to the manufacturer's instructions. One-microgram RNA was reverse-transcribed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Ten nanograms of cDNA was used for real-time PCR amplification, using commercially available Taqman probes for mouse Gapdh, Tnf, Glut3, IkBa, Bcl2, Bclx, Xiap, Il6 and Cxcl1 (Applied Biosystems). Data were normalized to the Gapdh levels, and analysed using the comparative C T method 30 , except for Fig. 4d , where data are presented as fold changes (2 2DCT (rtTA 1 )/2 2DCT (rtTA 2 ); mean rtTA 2 set to 1). NF-kB p65 DNA-binding activity assay. Five micrograms of nuclear extracts was used to determine p65 DNA-binding activity using an ELISA-based assay, according to the manufacturer's instructions (Active Motif TransAM). In brief, kB oligonucleotide-coated plates (in a 96-well format) were incubated for 1 h with the nuclear extracts. Specificity was achieved by incubation with anti-p65 primary antibodies for 1 h. HRP-conjugated secondary antibodies were used for the detection of p65 bound to the kB sequences. Reagents. Mouse TNF (used at 50 ng ml
21
) was from Apotech. Antibodies to cleaved caspase-3 (no. 9661), IKKb (2C8) and PARP (46D11) were purchased from Cell Signaling. Antibodies to p65 (C-20), c-Rel (C) and NEMO (FL-419) were purchased from Santa Cruz. Mouse anti-p53 was a gift from K. Helin. Rabbit anti-Flag (F7425) antibodies, 4-hydroxytamoxifen and doxycycline were purchased from Sigma. Infection of MEFs. In Fig. 1a , primary MEFs (passage 2) of the indicated genotypes were infected with adenoviruses (100 multiplicity of infection (m.o.i.)) expressing Cre recombinase (AdCre) or FlpO recombinase (AdFlpO) (University of Iowa, Gene Transfer Vector Core, http://www.uiowa.edu/ ,gene/). Six days later, cells were collected and subjected to the cytoplasmicnuclear fractionation protocol.
